CedeƱo, Prince Kurt G.
HRN: 21-47-62 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/22/2022
06/28/2022
IV
480
Q8h
Pcap- C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes